Natural Killer cells as COVID-19 therapy [electronic resource] / an interview with Pippa Kennedy.
Material type:![Sound](/opac-tmpl/lib/famfamfam/MU.png)
Audio interview.
Title from title frames.
Contents: The role of Natural Killer (NK) cells in viral infections -- Why NK cells are being investigated -- Induced pluripotent stem cell derived natural killer cells for SARS-CoV-2 therapy -- Benefits of this therapy -- Current stage of the clinical trial.
Access restricted to subscribers.
Mode of access: World Wide Web.